Literature DB >> 11294504

Terminal glycosylation of cystic fibrosis airway epithelial cells.

A D Rhim1, V A Kothari, P J Park, A E Mulberg, M C Glick, T F Scanlin.   

Abstract

Cystic fibrosis (CF) has a characteristic glycosylation phenotype usually expressed as a decreased ratio of sialic acid to fucose. The glycosylation phenotype was found in CF/T1 airway epithelial cells (deltaF508/deltaF508). When these cells were transfected and were expressing high amounts of wtCFTR, as detected by Western blot analysis and in situ hybridization, the cell membrane glycoconjugates had an increased sialic acid content and decreased fucosyl residues in alpha1,3/4 linkage to antennary N-acetyl glucosamine (Fuc(alpha)1,3/4GlcNAc). After the expression of wtCFTR decreased, the amount of sialic acid and Fuc(alpha)1,3/4GlcNAc returned to levels shown by the parent CF cells. Sialic acid was measured by chemical analysis and Fuc(alpha)1,3/4GlcNAc was detected with a specific alpha1,3/4 fucosidase. CF and non-CF airway cells in primary culture also had a similar reciprocal relationship between fucosylation and sialylation. It is possible that the glycosylation phenotype is involved in the pathogenesis of CF lung disease by facilitating bacterial colonization and leukocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11294504     DOI: 10.1023/a:1007156014384

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  34 in total

1.  Composition of mucoprotein fractions from duodenal fluid of patients with cystic fibrosis of the pancreas and from controls.

Authors:  Z DISCHE; P DI SANT'AGNESE; C PALLAVICINI; J YOULOS
Journal:  Pediatrics       Date:  1959-07       Impact factor: 7.124

2.  Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; J B Carlin; R Carzino; A Olinsky; P D Phelan
Journal:  Pediatr Pulmonol       Date:  1996-05

Review 3.  Terminal glycosylation in cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Biochim Biophys Acta       Date:  1999-10-08

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Golgi tubule traffic and the effects of brefeldin A visualized in living cells.

Authors:  N Sciaky; J Presley; C Smith; K J Zaal; N Cole; J E Moreira; M Terasaki; E Siggia; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

6.  Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates.

Authors:  A Scharfman; S Degroote; J Beau; G Lamblin; P Roussel; J Mazurier
Journal:  Glycobiology       Date:  1999-08       Impact factor: 4.313

7.  Defective acidification of intracellular organelles in cystic fibrosis.

Authors:  J Barasch; B Kiss; A Prince; L Saiman; D Gruenert; Q al-Awqati
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

8.  In vivo specificity of human alpha1,3/4-fucosyltransferases III-VII in the biosynthesis of LewisX and Sialyl LewisX motifs on complex-type N-glycans. Coexpression studies from bhk-21 cells together with human beta-trace protein.

Authors:  E Grabenhorst; M Nimtz; J Costa; H S Conradt
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

9.  Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator.

Authors:  H Zar; L Saiman; L Quittell; A Prince
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  8 in total

Review 1.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 2.  Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.

Authors:  A D Rhim; L Stoykova; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 3.  Terminal glycosylation and disease: influence on cancer and cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

4.  Modulation of expression in BEAS-2B airway epithelial cells of α-L-fucosidase A1 and A2 by Th1 and Th2 cytokines, and overexpression of α-L-fucosidase 2.

Authors:  Anna D Sobkowicz; Mary E Gallagher; Colm J Reid; Daniel Crean; Stephen D Carrington; Jane A Irwin
Journal:  Mol Cell Biochem       Date:  2014-01-28       Impact factor: 3.396

Review 5.  Specificity in cancer immunotherapy.

Authors:  Andrea Schietinger; Mary Philip; Hans Schreiber
Journal:  Semin Immunol       Date:  2008-08-05       Impact factor: 11.130

Review 6.  Glycosylation and the cystic fibrosis transmembrane conductance regulator.

Authors:  T F Scanlin; M C Glick
Journal:  Respir Res       Date:  2001-08-07

7.  Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions.

Authors:  Christopher J Day; Joe Tiralongo; Regan D Hartnell; Carie-Anne Logue; Jennifer C Wilson; Mark von Itzstein; Victoria Korolik
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

8.  Rhinovirus Infection Drives Complex Host Airway Molecular Responses in Children With Cystic Fibrosis.

Authors:  Kak-Ming Ling; Luke W Garratt; Erin E Gill; Amy H Y Lee; Patricia Agudelo-Romero; Erika N Sutanto; Thomas Iosifidis; Tim Rosenow; Stuart E Turvey; Timo Lassmann; Robert E W Hancock; Anthony Kicic; Stephen M Stick
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.